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group has argued that NKG2D displays some plasticityStructural and Energetic
and spatial reorganization upon binding and that thisAspects of Multispecific constitutes an “induced fit” [3]. Such conformational
flexibility would allow a single receptor to adopt theImmune Recognition by NKG2D
different conformations necessary for interactions with
structurally different ligands. Alternatively, multiple binding
specificities could arise without a substantial conforma-
tional change, if different ligands interacted with theThe multispecific immune receptor NKG2D binds dif-
receptor at different sites, or at one site but in differentferent ligands using a different set of energetically
fashions. Several NKG2D-ligand complex structuresdominant interface residues for each ligand.
have already shown that NKG2D uses a similar surface
and orientation to bind to different ligands.
Recognition in the immune system is critical for survival. In this issue of Structure, McFarland et al. [4] have
Failure to recognize and destroy foreign molecules now addressed the mechanism of the multispecificity
could allow a fatal infection to develop. Conversely, an of NKG2D by solving the structure of unliganded human
inappropriate attack on nonforeign molecules could NKG2D, comparing it to the ligand-bound complexes
lead to a serious autoimmune disease. NKG2D is a ho- and performing a computational and mutational analysis
modimeric C-type lectin-like molecule that has recently of several NKG2D-ligand complexes. The structure of
been recognized as a key immunological receptor on unliganded mouse NKG2D was already known [5]. The
natural killer cells and other immune effector cells [1]. computational analysis considers shape complementar-
It has multiple different ligands that resemble major his- ity and surface packing, polar interactions involving ion
tocompatibility class I molecules, but do not bind pep- pairs and hydrogen bonds, and protein-solvent interac-
tides or interact with 2-microglobulin. NKG2D interacts tions including a penalty for buried polar groups that
with these ligands, which are upregulated on the sur- are unsolvated [6]. This approach was used to identify
faces of pathogen-infected or tumor cells. The interac- the energetically dominant interface residues on NKG2D
tion triggers killing of the cell expressing the ligand. in the different ligand-bound complexes. The results
The mechanisms whereby this symmetrical homodi- suggest that different receptor residues dominate each
meric receptor can bind to multiple asymmetric ligands complex. Confirmation of this energetic modeling is pro-
are of interest, especially as some of the interactions vided by experimental analysis of changes in the free
energy of binding of proteins with alanine substitutionshave tight affinities in the low nanomolar range [2]. One
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at these positions. Free energy changes were calculated experimentally established that in several interactions,
key residues form hotspots that make major contribu-from the equilibrium binding constants determined by
surface plasmon resonance studies. tions to the binding-associated energy changes. For
example, 8 residues accounted for 85% of the bindingThe authors’ interpretation of the current structure
and data already published is that NKG2D undergoes energy in one growth hormone-receptor interaction. In a
biological world of protein-protein binding interactions,only minor structural changes on ligand binding and
these are not consistent with an induced fit. Rather, they where the range of net free energy changes is from
around 7 to 17 kcal/mol, [9] it is easy to see how aargue that despite using a similar part of the surface
of NKG2D for the interface, the different ligands make few residues can dominate the binding landscape. For
example, the formation of just one hydrogen bond couldinteractions that are substantially different in terms of
the residues that dominate the ligand-receptor interac- contribute up to 5 kcal/mol to the free energy change
of an interaction. When a net free energy change of 10tion. Thermodynamic studies have previously shown
that the NKG2D-ligand interactions can differ substan- kcal/mol equates to an affinity in the nanomolar range,
this is of great significance.tially, with different free energy changes and different
relative entropic and enthalpic contributions to these NKG2D is a highly conserved receptor, but even within
individuals, there is a substantial diversity of ligands andchanges [2].
To some extent, it is a semantic argument whether now, it seems, of binding interactions. These results
demonstrate how a family of ligand molecules, with sur-a given change with particular kinetics constitutes an
induced-fit. What is demonstrated experimentally is that faces that are broadly compatible with a receptor such
as NKG2D, could evolve divergently. The selection andsubtle conformational changes are associated with
binding to some ligands, and that the key interface resi- retention of key residues making strong interactions with
the receptor would allow functionally important diver-dues differ between the different interactions. Proteins
are not static and an experimentally determined struc- gence elsewhere in the protein to expand the scope of
immune surveillance by NKG2D.tural model typically represents the most energetically
probable conformation present in the experiment. Other
less energetically favorable conformations also exist Chris A. O’Callaghan1 and E. Yvonne Jones2
with lower probabilities of occurrence. The interaction 1Nuffield Department of Medicine
of a protein with a ligand may lower the free energy of University of Oxford
one of these alternative conformations, making it the John Radcliffe Hospital
dominant conformation in the ligand-bound state. If the Oxford OX3 9DU
conformational change is large it may become termed United Kingdom
an induced fit; if it is small, such as that of a few side 2 Division of Structural Biology
chains, then it may become termed a “lock and key” fit. Wellcome Trust Centre for Human Genetics
A further aspect is the time course or kinetics of the University of Oxford
conformational change. In this regard, chemists learn Roosevelt Drive
much about a reaction from studying the transition state Oxford OX3 7BN
characteristics, as well as the products and reactants. United Kingdom
In protein-protein reactions, the practical challenges in-
volved in studying transition states are significant, but Selected Reading
progress is being made. Of relevance here are observa-
tions of the kinetics of antibody interactions using fluo- 1. Cerwenka, A., and Lanier, L.L. (2001). Nat Rev Immunol 1, 41–49.
2. O’Callaghan, C.A., Cerwenka, A., Willcox, B.E., Lanier, L.L., andrescence studies [7]. These suggest that conformational
Bjorkman, P.J. (2001). Immunity 15, 201–211.diversity in the unbound antibody allows the rapid for-
3. Radaev, S., Rostro, B., Brooks, A.G., Colonna, M., and Sun, P.D.mation of multiple low-affinity promiscuous interactions.
(2001). Immunity 15, 1039–1049.
However, only certain ligands could then promote a 4. McFarland, B.J., Kortemme, T., Yu, S.F., Baker, D., and Strong,
slower induced-fit change in the antibody conformation. R.K. (2003). Structure 11, this issue, 411–422.
Nevertheless, in all these interactions the same forces 5. Wolan, D.W., Teyton, L., Rudolph, M.G., Villmow, B., Bauer, S.,
Busch, D.H., and Wilson, I.A. (2001). Nat. Immunol. 2, 248–254.are at play, with bond formation between the interacting
6. Kortemme, T., and Baker, D. (2002). Proc. Natl. Acad. Sci. USAmolecules and entropic changes, including those arising
99, 14116–14121.from solvent interactions.
7. James, L.C., Roversi, P., and Tawfik, D.S. (2003). Science 299,An interesting finding from this and other studies is
1362–1367.
that only a few residues dominate the energetics of 8. Wells, J.A., and de Vos, A.M. (1996). Annu. Rev. Biochem. 65,
the interactions. This is consistent with detailed studies 609–634.
9. Stites, W.E. (1997). Chem. Rev. 97, 1233–1250.such as those from the Genentech group [8]. They have
